Results 271 to 280 of about 297,437 (356)
Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity
M. Insenser+5 more
semanticscholar +1 more source
Abstract Aims To understand real‐world tirzepatide use among individuals without type 2 diabetes (T2D) diagnoses in a US electronic health record (EHR) database. Materials and Methods This retrospective, descriptive, cohort study used Veradigm's® Network EHR database linked with administrative claims.
Theresa Hunter Gibble+7 more
wiley +1 more source
Weight Management Strategies to Reduce Metabolic Morbidity in Women With Polycystic Ovary Syndrome. [PDF]
Diakosavvas M, Oyebode O, Bhide P.
europepmc +1 more source
ABSTRACT Background and Aims Androgenetic alopecia is the most common cause of hair loss in both men and women. The aim of this case‐control study was to investigate the role of phenotype (hair shape, thickness, and color) and demographic characteristics, including smoking history, in the development of androgenetic alopecia.
Afsaneh Sadeghzadeh Bazargan+6 more
wiley +1 more source
Mendelian randomization study showed no causality between metformin treatment and polycystic ovary syndrome. [PDF]
Lin L, Shen H, Wang Y.
europepmc +1 more source
Abstract The use of matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this review is the 12th update of the original article published in 1999 and brings coverage of the literature to the end of 2022.
David J. Harvey
wiley +1 more source
Ultrasound-derived fat fraction to assess liver steatosis in obese patients with polycystic ovary syndrome. [PDF]
Meng L, Wang J, Yang H, Hu Y, Yang Z.
europepmc +1 more source